Youll receive continued support with nutrition, lifestyle habits, and behavior-focused strategies to help make healthier choices more achievable
Since arriving on the market in 2005 for the treatment of Type 2 diabetes, Circana said, the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1s) have upended diabetes treatment and revolutionized how doctors and consumers approach weight management. These medications are designed to mimic the effects of a naturally occurring hormone that helps regulate blood sugar and slows digestion, which promotes the feeling of satiety, Circana added, noting that the first GLP-1 medication was approved for weight loss in 2014
Wu Shugeng, Feed Research Institute (CAAS), China Updates Copyright 2022 Li, Wen, Yu, Li, Wang, Qiao, Song and Huang
What do statins, SGLT2 inhibitors, and GLP-1 receptor agonists have in common
Int J Anat Res